Short Interest in Haleon plc (NYSE:HLN) Declines By 7.7%

Haleon plc (NYSE:HLN) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totalling 17,810,000 shares, a decline of 7.7% from the June 30th total of 19,300,000 shares. Based on an average daily volume of 4,760,000 shares, the short-interest ratio is currently 3.7 days. Approximately 0.4% of the shares of the stock are sold short.

Institutional Trading of Haleon

Institutional investors have recently modified their holdings of the business. Hexagon Capital Partners LLC lifted its holdings in Haleon by 107.3% in the fourth quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock valued at $35,000 after buying an additional 2,193 shares during the period. Pinnacle Bancorp Inc. lifted its holdings in Haleon by 853.4% in the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock valued at $39,000 after buying an additional 4,267 shares during the period. Cultivar Capital Inc. acquired a new position in Haleon in the second quarter valued at $40,000. Allspring Global Investments Holdings LLC acquired a new position in Haleon in the first quarter valued at $43,000. Finally, Tower Research Capital LLC TRC lifted its holdings in Haleon by 146.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,398 shares of the company’s stock valued at $44,000 after buying an additional 3,211 shares during the period. Institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of NYSE HLN traded up $0.17 during midday trading on Thursday, reaching $9.32. 4,923,416 shares of the company were exchanged, compared to its average volume of 5,212,049. The stock’s 50-day moving average price is $8.61 and its 200-day moving average price is $8.42. The stock has a market cap of $42.56 billion, a P/E ratio of 31.07, a PEG ratio of 2.62 and a beta of 0.24. Haleon has a one year low of $7.70 and a one year high of $9.49. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last posted its earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Haleon had a net margin of 9.68% and a return on equity of 13.17%. The firm had revenue of $3.70 billion for the quarter, compared to analysts’ expectations of $3.71 billion. On average, sell-side analysts anticipate that Haleon will post 0.47 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have commented on HLN. Berenberg Bank began coverage on shares of Haleon in a research report on Wednesday, June 5th. They set a “buy” rating for the company. HSBC assumed coverage on shares of Haleon in a research report on Wednesday, April 17th. They set a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, Haleon currently has an average rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.